PRN RESEARCH LTD

Company number 13737595 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

PRN RESEARCH LTD - Analysis Report

Company Number: 13737595

Analysis Date: 2025-07-20 13:29 UTC

Financial Health Assessment for PRN RESEARCH LTD


1. Financial Health Score: B+

Explanation:
PRN RESEARCH LTD shows strong liquidity and a solid equity base with an improving financial position over the last two years. The company maintains a healthy cash reserve and positive working capital, indicating good short-term financial stability. However, the relatively small size and limited asset diversity, combined with modest liabilities, suggest room for growth and improvement before reaching an "A" grade.


2. Key Vital Signs

Vital Sign Value (2024) Interpretation
Current Assets £125,211 Sufficient short-term resources to meet obligations.
Cash at Bank £104,681 Strong cash position, essential for day-to-day operations.
Debtors £20,530 Moderate receivables; manageable credit risk.
Current Liabilities £8,029 Low near-term debts, indicating limited financial pressure.
Net Current Assets £117,182 Positive working capital; good liquidity buffer.
Shareholders’ Funds £117,182 Solid equity base; company funded well by owners’ capital.
Year-on-Year Equity Growth +27% (from £92,301 to £117,182) Indicates retained earnings and business growth.

Additional Observations:

  • The company’s liabilities have significantly decreased from £30,367 in 2023 to £8,029 in 2024, a positive sign of improving financial health.
  • Cash reserves reduced slightly but remain strong, ensuring a healthy cash flow.
  • No long-term fixed assets or debts reported, indicating a lean asset base focused on current assets.

3. Symptoms Analysis & Diagnosis

Symptoms of Financial Health:

  • Healthy Cash Flow: The company holds a large cash balance relative to its liabilities, akin to a patient with a good fluid balance—vital for operational health.
  • Strong Working Capital: Net current assets are positive and increasing, showing the business can comfortably cover its short-term debts, like a heart pumping efficiently to sustain the system.
  • Equity Growth: The rising shareholders' funds reflect profitable operations or retained earnings, indicating a growing and resilient financial foundation.
  • Low Liability Burden: The substantial reduction in current liabilities suggests the company is successfully managing its debts, lowering financial stress.

Diagnosis:
PRN RESEARCH LTD is financially sound with no immediate signs of distress. The company exhibits a stable liquidity position with adequate cash reserves and low debt levels, suggesting it is well-positioned to meet obligations and fund operations. The growth in equity points to profitability or capital contributions, a positive sign of sustainable business health. However, the company’s size and asset base remain modest, limiting its financial resilience against larger shocks.


4. Prognosis and Recommendations

Prognosis:
If current trends continue, PRN RESEARCH LTD is likely to maintain a healthy financial position. With strong cash flow and improving equity, the company should be able to invest in growth opportunities or cushion against unforeseen expenses. However, as a small entity in the medical practice industry, continued vigilance on cash management and receivables is crucial.

Recommendations:

  • Enhance Revenue Tracking: Implement robust debtor management to reduce collection times and improve cash flow even further, addressing any potential receivables "symptoms."
  • Build Asset Base: Consider strategic investment in fixed assets or technology to enhance operational capacity and long-term value, akin to strengthening the company’s "muscle mass."
  • Monitor Tax Liabilities: Corporation tax remains a notable short-term creditor; regular planning can prevent surprises and preserve liquidity.
  • Financial Planning: Maintain regular financial health "check-ups" with forecasting and scenario analysis to anticipate and manage risks proactively.
  • Growth Strategy: Explore opportunities to scale operations while maintaining the strong liquidity buffer, ensuring the company’s financial "immune system" stays robust.

Executive Summary

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.